Total Funding
37
41
Total FundingSeries B raised
Growth Score
-3 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
83048
SILKTECH focuses on innovating and developing silk-derived protein (SDP) products for ophthalmic applications
- Brian Lawrence: Chief Executive Officer
- Brian Levy: ChairmanPast Role: Ocunexus Therapeutics, Chief Executive Officer
About the Company
SILKTECH focuses on innovating and developing silk-derived protein (SDP) products for ophthalmic applications. The company’s patented SDP material is currently being developed as a novel compound for the treatment of patients with dry eye disease. SILKTECH is based in Plymouth, MN and is financially backed by a combination of angels, grants and
recently from a financing round by Skyview Ventures .
